Literature DB >> 7673394

Clinical review 73: Medical treatment of androgen-dependent hirsutism.

R S Rittmaster1.   

Abstract

Although hirsutism is more a cosmetic and psychosocial problem than a disease, hirsute women are often some of the most grateful patients in an endocrinologist's practice. The combination of mechanical hair removal and judicious use of medications will improve hair growth in most women. Unfortunately, no drug is approved by regulatory agencies in North America for treatment of hirsutism. Well designed comparative studies with objective end points are needed to demonstrate which drugs work best in which hirsute women. Because pharmaceutical companies are reluctant to market drugs for women of child-bearing age, there has been little industry support for such studies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673394     DOI: 10.1210/jcem.80.9.7673394

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  Estrogen-progestagen therapy in the management of the polycystic ovary syndrome.

Authors:  J C Marshall
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 2.  Approach to patients with hirsutism.

Authors:  R Sakiyama
Journal:  West J Med       Date:  1996-12

Review 3.  A risk-benefit assessment of pharmacological therapies for hirsutism.

Authors:  E Carmina
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

4.  Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.

Authors:  Y Sahin; F Bayram; F Keleştimur; I Müderris
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

Review 5.  Role of GnRH drive in the pathophysiology of polycystic ovary syndrome.

Authors:  M P Leondires; S L Berga
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.